Arvee Laboratories (India) Ltd. (ARVEE.NS) NSE
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
Arvee Laboratories (India) Ltd.
Sector
Basic Materials
Industry
Chemicals - Specialty
Employees
65
First IPO Date
February 22, 2018
Key Executives
| Name | Title | Pay | Year Born |
| Shalin Bharatbhai Chokshi | Whole-Time Director | 0 | 1984 |
| Saurin Ajitbhai Gandhi | Chief Financial Officer & Additional Director | 0 | 1983 |
| Shalin Sudhakarbhai Patel | Chairman & MD | 0 | 1978 |
| Raina Singh Chauhan | Company Secretary & Compliance Officer | 0 | N/A |
Description
Arvee Laboratories (India) Ltd., established in 2012 and headquartered in Ahmedabad, India, specializes in the production and distribution of various specialized chemicals throughout the country. The company's product line includes a range of polymer modifiers, such as dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate. Additionally, Arvee Laboratories manufactures intermediates critical for contrast media, supplying compounds like 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, dimethyl 5-aminoisophthalate, 3,5-dinitrobenzoic acid, and 3,5-diamino benzoic acid. The firm also provides drug intermediates, specifically 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4-amino pyridine, and 2-chloro-5-nitrobenzoic acid. Beyond its domestic sales, Arvee Laboratories actively exports its chemical products.